Collaborations Pharmaceuticals

Startup

Collaborations Pharmaceuticals, Inc.® (CPI) is a privately owned company that performs research and development on innovative therapeutics with a preclinical pipeline of treatments for rare and neglected diseases. We partner with academics and companies to identify and translate early preclinical stage assets. Our goal is to bring multiple therapeutics to the clinic using our machine learning technologies (Assay Central) as well as curated model bundles (MegaTox®, MegaTrans® and MegaPredict®). We have also developed generative models for molecule design (MegaSyn). Learn more about our preclinical and computational approaches to drug discovery and toxicity prediction please see http://www.collaborationspharma.com/